Bergmeijer, T.O.; Yasmina, A.; Vos, G.J.A.; Janssen, P.W.A.; Hackeng, C.M.; Kelder, J.C.; Verma, S.S.; Ritchie, M.D.; Gong, L.; Klein, T.E.;
et al. Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. Genes 2020, 11, 1068.
https://doi.org/10.3390/genes11091068
AMA Style
Bergmeijer TO, Yasmina A, Vos GJA, Janssen PWA, Hackeng CM, Kelder JC, Verma SS, Ritchie MD, Gong L, Klein TE,
et al. Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. Genes. 2020; 11(9):1068.
https://doi.org/10.3390/genes11091068
Chicago/Turabian Style
Bergmeijer, Thomas O., Alfi Yasmina, Gerrit J. A. Vos, Paul W. A. Janssen, Christian M. Hackeng, Johannes C. Kelder, Shefali S. Verma, Marylyn D. Ritchie, Li Gong, Teri E. Klein,
and et al. 2020. "Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention" Genes 11, no. 9: 1068.
https://doi.org/10.3390/genes11091068
APA Style
Bergmeijer, T. O., Yasmina, A., Vos, G. J. A., Janssen, P. W. A., Hackeng, C. M., Kelder, J. C., Verma, S. S., Ritchie, M. D., Gong, L., Klein, T. E., ICPC investigators, de Boer, A., Klungel, O. H., ten Berg, J. M., & Deneer, V. H. M.
(2020). Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention. Genes, 11(9), 1068.
https://doi.org/10.3390/genes11091068
